SCANREP: Reliability of 3D Lower Limb Scanning

January 12, 2022 updated by: Jason Wilken, University of Iowa
3D limb scanning systems have recently been implemented for the clinical fitting of prosthetic and orthotic devices due to substantial decreases in costs. However, little data is available regarding the repeatability and validity of systems currently in use. In this study the investigators seek to evaluate the repeatability and validity of multiple lower limb measurements obtained using low-cost 3D limb scanning technology.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Two groups of subjects will be recruited for this study. The first group (Group 1) will consist of healthy able-bodied individuals with no history of lower extremity trauma. The second group (Group 2) will consist of individuals with unilateral, below knee functional deficits that require an AFO (ankle foot orthosis) for daily activities (e.g. fracture, muscle and/or nerve injury, ankle arthritis, or peripheral neurologic disease).

The investigators will obtain a brief medical history to identify major medical conditions or prior injuries that could influence limb geometry, and lead to reliance on an AFO for Group 2 participants.

A 3D representation of each participant's lower limb geometry will be obtained using a Structure Core scanner (Occipital, Inc.) which uses an infrared structured light projector to construct a 3D image of an object. The scanner is connected to an iPad; to operate the user rotates the iPad camera around the desired object. In seconds, the entire geometry is digitally reconstructed. Measurements will be evaluated using digital imaging analysis software (Standard Cyborg, Inc.). The investigators will evaluate concurrent validity by directly comparing software-based measurements from limb scans, with direct measurements on the same individual collected using digital calipers. The investigators will determine repeatability of each technique by conducting three identical limb scans and actual physical measurements at two time points on the same day in each individual, and then comparing the results between time points. The interior of the AFO worn by participants in Group 2 will also be scanned to obtain its geometry for comparison with measurements obtained from each individual's limb.

Validity and repeatability will be assessed using measurements at multiple locations on the lower leg. Limb measurements will include 1) width of the metatarsal heads, 2) width of the calcaneus, 3) foot length, 4) foot height, 5) arch height, 6) medial-lateral width between ankle malleoli, 7) minimum circumference above the ankle malleoli, 8) maximum calf circumference , 9) medial-lateral width of the knee condyles 10) anterior-posterior width at mid patellar tendon, 11) distance from bottom of foot to tibial tubercle.

Concurrent validity will be determined using the intra-class correlation coefficient and absolute error (root mean square error) for comparisons between measurements from limb scanning and the calipers. Reliability will be determined using the intra-class correlation coefficient and the minimal detectable change value for comparisons over time.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Two groups of subjects will be recruited for this study. The first group (Group 1) will consist of healthy able-bodied individuals with no history of lower extremity trauma. The second group (Group 2) will consist of individuals with unilateral, below knee functional deficits that require an AFO for daily activities (e.g. fracture, muscle and/or nerve injury, ankle arthritis, or peripheral neurologic disease).

Description

GROUP 1 (Completed)

Patient Inclusion criteria

  • Ages: 18-75
  • Healthy individuals without a current complaint of lower extremity pain, spine pain, active infections or medical or neuromusculoskeletal disorders that have limited participation in work or exercise in the last 6 months
  • Ability to perform a full squat without pain
  • Able to read and write in English and provide written informed consent

Patient Exclusion criteria

  • Diagnosed moderate or severe brain injury
  • Diagnosis of a physical or psychological condition that would preclude testing (e.g. cardiac condition, clotting disorder, pulmonary condition)
  • Current complaint of pain or numbness in the spine
  • Uncorrected visual or hearing impairments that limit the ability to understand or comply with instructions given during testing
  • Require an assistive device
  • Open/unhealed wounds on lower extremity.
  • BMI greater than 35

GROUP 2 (Recruiting)

Patient Inclusion criteria

  • Ages: 18-75
  • Daily AFO use to address unilateral below knee functional deficits (e.g. fracture, muscle and/or nerve injury, ankle arthritis, or peripheral neurologic disease)
  • Ability to stand independently without use of an assistive device (Cane, crutch, etc)
  • Ability to safely bear full body weight on affected limb without use of an AFO or other protection
  • Able to read and write in English and provide written informed consent

Patient Exclusion criteria

  • Use of an AFO that crosses the knee (includes Knee brace or similar)
  • Open/unhealed wounds on lower extremity
  • Uncorrected visual or hearing impairments that limit the ability to understand or comply with instructions given during testing
  • BMI greater than 35
  • Diagnoses of a moderate to severe brain injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1: Healthy Able-bodied Individuals (Completed)
Healthy able-bodied individuals with no history of lower extremity trauma.
A 3D representation of each participant's lower limb geometry will be obtained using a Structure Core scanner (Occipital, Inc.) which uses an infrared structured light projector to construct a 3D image of an object. The scanner is connected to an iPad; to operate the user rotates the iPad camera around the desired object. In seconds, the entire geometry is digitally reconstructed.
Group 2: Individuals Requiring AFO Use (Recruiting)
Individuals with unilateral, below knee functional deficits that require an AFO for daily activities (e.g. fracture, muscle and/or nerve injury, ankle arthritis, or peripheral neurologic disease).
A 3D representation of each participant's lower limb geometry will be obtained using a Structure Core scanner (Occipital, Inc.) which uses an infrared structured light projector to construct a 3D image of an object. The scanner is connected to an iPad; to operate the user rotates the iPad camera around the desired object. In seconds, the entire geometry is digitally reconstructed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Width of the metatarsal heads
Time Frame: Less than 2 days
Distance from the medial aspect of the first metatarsal head to the lateral aspect of the fifth metatarsal head.
Less than 2 days
Width of the calcaneus
Time Frame: Less than 2 days
Distance from the medial aspect of calcaneus parallel to lateral aspect of calcaneus.
Less than 2 days
Foot length
Time Frame: Less than 2 days
Distance from the most posterior aspect of calcaneus to the most anterior toe (1st or 2nd).
Less than 2 days
Foot height
Time Frame: Less than 2 days
Distance from the most superior point on the foot distal to the tibialis anterior insertion.
Less than 2 days
Arch height
Time Frame: Less than 2 days
Dorsum height at 50% foot length.
Less than 2 days
Medial-lateral ankle malleoli width
Time Frame: Less than 2 days
Distance from the lateral malleolus to the medial malleolus.
Less than 2 days
Minimum ankle circumference
Time Frame: Less than 2 days
Minimum ankle circumference above the ankle malleoli. Must be less than 10 cm proximal to the ankle malleoli.
Less than 2 days
Maximum calf circumference
Time Frame: Less than 2 days
Maximum calf circumference greater that 5 cm distal to the knee condyles.
Less than 2 days
Width of the knee condyles
Time Frame: Less than 2 days
Distance from the medial condyle to the lateral condyle.
Less than 2 days
Anterior-posterior width at patella
Time Frame: Less than 2 days
Distance from mid patellar tendon to a parallel point most posterior on the back of the knee.
Less than 2 days
Tibial tubercle height
Time Frame: Less than 2 days
Distance from the floor to tibial tubercle.
Less than 2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 27, 2019

Primary Completion (ACTUAL)

December 12, 2019

Study Completion (ANTICIPATED)

May 1, 2022

Study Registration Dates

First Submitted

July 22, 2019

First Submitted That Met QC Criteria

July 24, 2019

First Posted (ACTUAL)

July 25, 2019

Study Record Updates

Last Update Posted (ACTUAL)

January 13, 2022

Last Update Submitted That Met QC Criteria

January 12, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 201905871

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Foot Injuries and Disorders

Clinical Trials on Structure Sensor

3
Subscribe